Puma Biotechnology, Inc.

NasdaqGS:PBYI 주식 보고서

시가총액: US$142.4m

Puma Biotechnology 대차 대조표 상태

재무 상태 기준 확인 6/6

Puma Biotechnology 의 총 주주 지분은 $71.1M 이고 총 부채는 $78.1M, 이는 부채 대 자기자본 비율을 109.8% 로 가져옵니다. 총자산과 총부채는 각각 $220.7M 및 $149.6M 입니다. Puma Biotechnology 의 EBIT는 $33.0M 이며 이자보상배율은 3.7 입니다. $96.7M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

109.8%

부채 비율

US$78.08m

부채

이자 보상 비율3.7x
현금US$96.73m
주식US$71.09m
총 부채US$149.63m
총 자산US$220.72m

최근 재무 상태 업데이트

Recent updates

Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest

Nov 14
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest

Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment?

Sep 07
Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment?

Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop

Aug 15
Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop

The Market Doesn't Like What It Sees From Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Earnings Yet As Shares Tumble 25%

Jun 07
The Market Doesn't Like What It Sees From Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Earnings Yet As Shares Tumble 25%

Here's Why We Think Puma Biotechnology (NASDAQ:PBYI) Might Deserve Your Attention Today

Jun 05
Here's Why We Think Puma Biotechnology (NASDAQ:PBYI) Might Deserve Your Attention Today

We Like The Quality Of Puma Biotechnology's (NASDAQ:PBYI) Earnings

May 09
We Like The Quality Of Puma Biotechnology's (NASDAQ:PBYI) Earnings

Puma Biotechnology: A Story In Flux Heading Into Mid-2024

May 05

Is There An Opportunity With Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 46% Undervaluation?

Apr 10
Is There An Opportunity With Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 46% Undervaluation?

There's Reason For Concern Over Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Massive 31% Price Jump

Mar 01
There's Reason For Concern Over Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Massive 31% Price Jump

Here's Why Puma Biotechnology (NASDAQ:PBYI) Has A Meaningful Debt Burden

Dec 27
Here's Why Puma Biotechnology (NASDAQ:PBYI) Has A Meaningful Debt Burden

Puma Biotechnology (NASDAQ:PBYI) Has A Somewhat Strained Balance Sheet

Sep 08
Puma Biotechnology (NASDAQ:PBYI) Has A Somewhat Strained Balance Sheet

Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%

Apr 17
Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%

We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt

Dec 14
We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt

Puma Biotechnology, Takeda enter licensing agreement for cancer treatment alisertib

Sep 20

Puma Biotechnology (NASDAQ:PBYI) Takes On Some Risk With Its Use Of Debt

Sep 05
Puma Biotechnology (NASDAQ:PBYI) Takes On Some Risk With Its Use Of Debt

재무 상태 분석

단기부채: PBYI 의 단기 자산 ( $156.8M )이 단기 부채( $110.4M ).

장기 부채: PBYI 의 단기 자산( $156.8M )이 장기 부채( $39.2M ).


부채 대 자본 내역 및 분석

부채 수준: PBYI 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: PBYI 의 부채 대 자기자본 비율은 지난 5년간 548.2% 에서 109.8% 로 감소했습니다.

부채 범위: PBYI 의 부채는 영업 현금 흐름 ( 43.2% )에 의해 잘 충당되었습니다.

이자 보장: PBYI 의 부채에 대한 이자 지급EBIT( 3.7 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기